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Thymocyte cultures from C3H/HeJ mice  were 
stimulated for proliferative  responses  with  purified 
preparations of interleukin 1 (IL 1) and  interleukin 
2 (IL 2). Synergistic  responses  were  obtained  in  the 
absence of  mitogen. In the  presence of excess IL 2. 
the  thymocyte  proliferation  response  was  strictly 
dependent on the amount of IL 1 in  the  cultures. 
Antibodies to IL 1 inhibited  the  response  in  a  dose- 
dependent  manner.  The  combination  of IL 1 plus IL 
2 induced  the  appearance of IL 2 receptors on mu- 
rine thymocytes as detected  with  a  monoclonal an- 
tibody  directed  against  the IL 2 receptor.  Neither IL 
1 nor IL 2 alone had this effect. The  thymic  subpop- 
ulation  found to become IL 2 responsive upon IL 1 
stimulus was the peanut  agglutinin-negative (PNA-) 
medullary  fraction. 
Interleukin 1 and 2 (IL 1 and IL 2) play important roles 
in the generation of T and B cell immune reactivities 
(reviewed in  References 1-4). A well-established function 
of the macrophage  product IL 1 is the promotion of IL 2 
production from T cells (5. 6). IL 2 appears to  be required 
for the  sustained long-term growth of T cells and for the 
generation of cytotoxic T cell responses (7-9). Both IL 1 
and IL 2 have  been  shown to  augment the proliferative 
response of thymocytes to suboptimal doses of T cell 
mitogens like concanavalin A (Con A) (10, 1 1).  The thymic 
subpopulation  with  capability  to  proliferate  upon mitogen 
and IL 1 stimulus  was found  to be the  peanut agglutinin- 
negative (PNA-)' medullary type (12). This stimulation 
has been shown to result in the release of IL 2 by the 
PNA- cells and  the  subsequent utilization of the IL 2 by 
the  same cell population (1 3). 
The  question  arose as to  whether  the induction of IL 2 
production is the only function of IL 1. Experiments 
detailed in this paper suggest that within the PNA- 
thymic  subpopulation, IL 1  exerts  a  function in addition 
to the generation of IL 2. This second function of IL 1 
enables PNA- cells to utilize IL 2 for subsequent prolif- 
eration. IL 2 receptor expression  seems to be regulated 
by synergistic  action of IL 1 and IL 2 in  the thymocyte 
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cultures. PNA-positive  (PNA+) thymocytes  in the presence 
of IL 1 were unable  to  make  use of the IL 2 that was 
provided. This indicated that IL 1 itself is not directly 
acting  on  immature  thymocytes  to become IL 2 respon- 
sive, but  rather synergizes  with IL 2 to  make PNA- cells 
responsive to IL 2. 
MATERIALS AND METHODS 
Mice. Male C3H/HeJ mice were purchased from the Jackson 
Laboratory,  Bar  Harbor, ME.  All animals were  used at 4 to 9 wk of 
age. 
(GIBCO) and  was supplemented with  10%  heat-inactivated  fetal calf 
Culture medium. The culture medium  used was RPMI 1640 
serum (FCS). L-glutamine (2 X M), HEPES (0.02 M). 2-mercap- 
toethanol (4 X M), and gentamicin (50 pg/rnl). 
by Hilfiker et al. (1 4). EL-4 thymoma cells  were stimulated  in RPMI 
Preparation of IL 2. IL 2 preparations were prepared as described 
1640  containing 0.5% heat-inactivated FCS with phorbol myristic 
acetate (1 0 ng/ml). After 48  hr,  the c llfree supernatant  was concen- 
trated on a Amicon PM-10 membrane; proteins were precipitated 
with  ammonium  sulfate (80% saturation)  and applied onto a  phenyl- 
Sepharose column. IL 2 was eluted with  40% ethanediol in  0.16 M 
ammonium  sulfate. After concentration of the IL 2-contalnlng  frac- 
tions  on an Amicon PM- 10 membrane,  the material was applied onto 
a Sephadex G- 100 column. The IL 2  activity  eluted  with a n  apparent 
m.w. of approximately  32.000. 
Recombinant human IL 2 was kindly provided by Cetus Corp. The 
material was 98% pure,  containing  0.02 ng/ml endotoxin, and  had 
an IL 2 concentration of 2 X 10'  U/ml. 
Assayfor IL 2 activity. The  amount of  IL 2  in supernatants  was 
assayed  with a n  IL 2-dependent cell line, W-2 (1 5). Thymidine  incor- 
poration after a 20-hr  incubation  and a 4-hr pulse with 1 .O pCi of 
[3H]thymidine (3HTdR; specific  activity 50 Ci/mmol; Amersham In- 
ternational Ltd., Amersham. U.K.) was determlned. Results  are ex- 
pressed in  units as described by Farrar  et  al.  (16). 
cells and  was purified by gel filtration and immunoaffinity chro- 
Preparation of1L 1. IL 1 was obtained  from  superinduced P388D1 
matography [ 17). 
Preparation of anti-IL 1 antibodies. Anti-IL 1 antibodles were 
raised in a goat as described (17).  The IgG fraction from the  heat- 
chromatography after  ammonium  sulfate precipitation. The protein 
inactivated serum was isolated on DEAE cellulose ion-exchange 
concentration  was adjusted to 5 to 10 mg/ml. 
Assayfor IL I activity. IL 1 was  measured  in  the C3H/HeJ mouse 
thymocyte assay [18).  One unit of IL 1 per milliliter induced 50% of 
the maximal  thymocyte  proliferative  response. 
Thymocyte  prollferatfon. Thymocytes (1 to 3 X lo5 per culture) 
from C3H/HeJ mice were cultured in 0.2-1111 volumes for 3 days. 
Varying amounts of either IL 2 and/or IL 1 preparations were  added 
to  these  cultures. 3HTdR uptake  was measured  in a 7-hr pulse, and 
results  are expressed  in  cpm of duplicate or triplicate cultures f SD. 
Separation of PNA+ and PNA- thymocytes byfluorescence-ac- 
subagglutinating  concentrations of PNA-FITC' (12). PNA-FITC at  a 
tluated cell sorting. Thymocytes  were separated  after  staining  with 
concentration of 5 pg lectin/ml was used for  staining lo7 cells/0.25 
ml for  30  min  at 4°C. The cells were diluted to 5 X 10' cells/ml 
(Ortho Diagnostic System). Cells in channels 0 through 32 were 
(without  washing)  for  sorting  in a fluorescence-activated cell sorter 
collected as PNA- fraction,  and  in  channels 38 through  100 as PNA+ 
fraction. After sorting. samples of fractionated thymocytes were 
washed.  then resuspended in  culture medium; the viable  cells  were 
routinely  analyzed to  assess purity. The sorted cell fractions were 
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counted In a hemacytometer. 
IL 2 receptor  determination. Glutaraldehyde-fixed sheep  eryth- 
rocytes 15 X lo6) were  added to  triplicate  cultures of 4 X lo5 thymo- 
cytes,  and  the cells  were  kept on ice for 30 min  in the  presence or 
absence of culture fluid (100 pl) from a rat hybridoma cell line  that 
secretes  antibodies directed against  the  murine IL 2 receptor (AMT 
ice with '251-labeled fragments of a sheep anti-rat IgG (100 pl 
13) ( 1  9).  The cells  were then  incubated for an additional 60 min on 
of a 1/10 diluted stock  with specific  activity of 12 rCi/pg: Amersham 
determined by subtracting nonspecifically  bound  radiolabel of par- 
International Ltd.). The cells  were washed,  and specific binding  was 
allel cultures  and  was expressed as cpm f SD. 
RESULTS 
Induction of thymocyte proliferation. Both IL 1 and IL 
2 have been characterized by their capacity to induce 
synergistic proliferative responses  after  stimulation  with 
suboptimal amounts of T cell mitogens (10,  11).  The IL 
1-dependent mitogenesis appears to be due at least in 
part to the  subsequent production,  release, and  use of IL 
2 (6). The  results  shown  in Figure 1 demonstrate that in 
the  absence of mitogen, purified preparations of IL 1 and 
IL 2  act  synergistically  to  induce thymocyte proliferation. 
IL 1  alone (up to 0.5 U/culture) induced less than 1000 
cpm 3HTdR uptake  in  cultures  with 3 X lo5 or 1 X lo5 
thymocytes. IL 2  preparations that differed in source as 
well as  in IL 2  concentration  resulted  in  identical dose- 
response  curves  for the IL 1 effect. In panel A, the IL 1- 
induced mitogenesis in the presence of 10 U partially 
purified murine IL 2 was compared with the mitogenic 
response  in the presence of 5 U of recombinant  human 
IL 2.  The resulting 3HTdR uptake  data from all  cultures 
fi t  a straight line  with a correlation coefficient of I-2 = 
0.99  1. Similar data were obtained  with  cultures  contain- 
ing  1 X 1 O5 thymocytes  stimulated  with  varying amounts 
of purified IL 1 in the presence of 5 U or 20 U of recom- 
binant  human IL 2  (panel B). In this  case,  the line  with 
the best  fit  had  a  correlation coefficient of 3 = 0.983. 
Thus,  when providing excess IL 2  to the  cultures, i.e., IL 
2 concentrations that resulted in a plateau mitogenic 
response (9880 + 1300 cpm in  panel A and  1800 + 280 
cpm in panel B), the level of proliferation was strictly 
dependent on the  amount of IL 1 added. 
Inhibition of thymocyteproliferation. Recently, highly 
specific goat antibodies  to IL 1 were developed (17).  The 
A 
- 
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x lo5 C3H/HeJ thymocytes with twofold serial dilutions of purified IL 1. 
Figure 1 .  Induction of proliferative responses of (A) 3 X lo5 and (E) 1 
In A, 10 U of partially purified murine 1L 2 (A) or 5 U of recombinant 
human IL 2 (a], and In E. 5 U (A] or 20 U (0) of recomblnant human IL 2 
were present in the cultures. Recombinant IL 2 alone in B resulted in 
3HTdR incorporation without any dose dependency (cpm x uptake 
by 50 U = 2.0 f 0.1: 25 U = 1.7 f 1.0; 12.5 U = 2.2 f 1.0:  6 U = 1.6 f 
0.1: 3 U = 2.1 f 0.7). 
anti-IL 1 IgG fraction has been shown  to  inhibit specifi- 
cally IL 1-induced proliferation but  not the IL 2-depend- 
ent proliferation of an IL 2-dependent cell line (1 7).  The 
anti-IL 1 IgG fraction  inhibited  in  a  dose-dependent man- 
ner IL 1 -induced thymocyte proliferation in the presence 
of excess amounts of IL 2 (Table I). The proliferative 
response  resulting from the concerted action of IL 1 and 
IL 2  was  inhibited at least as well as the costimulation 
by IL 1 and Con A. 
Induction of IL 2 receptor  expression on thymocytes 
by IL 1 and IL 2. The  T cell proliferative response  to IL 2 
was  found  to be initiated via the interaction of IL 2 with 
its receptor on activated T cells (20). Monoclonal anti- 
bodies (AMT 13) directed against  the  murine IL 2 receptor 
(1 9) were employed to measure  the  amount of IL 2 recep- 
tors  on  the cell surface.  Table I1 shows that in the pres- 
ence of IL 1 and IL 2, significant numbers of AMT 13 
binding sites were induced. Neither IL 1  nor IL 2 by itself 
induced significant amounts of IL 2 receptor on thymo- 
cytes. A concentration of AMT 13 hybridoma superna- 
tant of 50% inhibited the IL l-induced proliferation to 
background levels (41,580 cpm to 3770 cpm). 
Target  cells for  the IL 1-induced  thymocyte  prolifer- 
ation. As reported earlier (1 3). the PNA+ subpopulation 
of the thymus does not produce IL 2 in response to 
stimulation  with IL 1 and mitogen. Thus,  this relatively 
immature population does not seem to be the target cell 
population for IL 1-mediated IL 2 production. To answer 
the  same question for the target cell of the IL 1-induced 
mitogenesis in  the presence of IL 2, C3H/HeJ thymocytes 
were stained  with  subagglutinating  doses of PNA-FITC 
and were separated  with  a cell sorter (1 2). Before sorting, 
16% of the thymocytes were only weakly positive (mean 
intensity  84)  and  79% were strongly  fluorescent  (mean 
intensity  525). Analysis of the sorted cells indicated that 
each population was  greater than  95% pure.  The data in 
Table I11 demonstrate  that PNA+ cells do not acquire IL 2 
responsiveness when exposed to IL 2. The synergistic 
TABLE I 
Inhibition of IL I-induced proliferation bV anti-IL 1 
SampleL 
Anti-IL 1 I@* (mgiml] 
0 0.5 0.25 0.125 
IL 1 + IL 2 60.1 f 1.5 8.9f 0.4 25.9 f 1.2 39.8 2 1.5 
ILl+ConA 5 .2f1 .7  1.7k0.1 2.320.0 3.6-cO.5 
(851  (571  133) 
(67) 1571 133) 
"Purifled murine IL 1 was present at  0.5 U/ml in the C3H/HeJ thy- 
mocyte cultures (3 X lo5 cells/culture) together  with either recombinant 
human IL 2  (20 U/ml) or Con A (1 pg/ml). 
Results are given as cpm X 1 0-3 f SD 3HTdR uptake. The numbers 
in parentheses represent the percent inhibition of thymocyte prolifera- 
tion. 
TABLE I1 
Induction of IL 2 receptor expression on thymocytes 
Samplea AMTl3 Binding 
Icpml 
Medium 
IL 1 
2,2502 120 
IL 2 
2.230 f 760 
IL 1 + IL 2  29,650 f 2,330 5.4802 410 
Con A supernatant 145.680 ? 8,740 
Cultures of 2 X 10' thymocytes  were supplemented wlth murine IL 1 
(0.5 U/ml) and/or purified murine IL 2  (40 U/ml) or wlth 30%  supernatant 
of C3H spleen cells (1 O'/ml) incubated for 24 hr in the presence of Con A 
(5 rglml). 
Specific  binding of monoclonal antibodies directed against the murine 
IL 2 receptor  was  measured on 4 X lo5 cells/sample. 
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TABLE I11 
IL I-induced  prollferation of thymlc subpopulatlons" 
Sampleb Unsorted PNA- PNA* 
IL 2 7.7 f 0.7 16 .6 f  1.3  1.2 f 0.1 
IL 1 0.3 k 0.0 
IL 2 + IL 1 
0.9 k 0.2 0.8 f 0.1 
127.1 f 1.9 1 9 7 . 8 f 2 . 1   2 . 8 f 0 . 8  
IL2+ConA 85.8 f 2.8  141.8 f 7.0 2.3 f 0.1 
Results are given as cpm x 10"' f SD 3HTdR uptake. 
were supplemented with recombinant human IL 2 (20 U/ml) and/or 
'Cultures of 10" unseparated or PNA- or PNA+ C3H/HeJ thymocytes 
purified murlne IL 1 (0.5 U/ml) and/or Con A (1 &ml). 
effect of IL 1 and IL 2 seen with the unseparated thymo- 
cytes is also observed with PNA- subpopulation. IL 2 
alone was  also  able  to  induce  substantial proliferative 
responses in the PNA- population. However, this re- 
sponse  was  small compared with the synergistic activity 
of IL 1 and IL 2. 
DISCUSSION 
Although the involvement of IL 1 in IL 2 production by 
murine T cells is well established (6). the precise mecha- 
nism has not yet been  elucidated. It  is well documented 
that  the  sustained proliferation of activated  T cells is a 
property unique  to IL 2 (4, 20).  Thus, one mode of action 
of IL 1 seems to be the IL 1-induced production and 
utilization of IL 2 by activated  T cells. The  data presented 
in this report show, however, that IL 1 may have an  
additional role in  T cell activation. Induction of IL 2 by IL 
1 (an action previously demonstrated  with  mature PNA- 
thymocytes  (13)) cannot explain the synergism between 
IL 1 and IL 2. All thymocyte cultures  contained  excess 
amounts of purified IL 2  in  order  to avoid the  enhancing 
effect of additional IL 2 produced upon the IL 1 stimulus. 
The utilization of purified IL 2  preparations from differ- 
ent sources and  the  use of C3H/HeJ endotoxin-low re- 
sponder mice make  it unlikely that other  contaminating 
factors  or lipopolysaccharide are responsible for this mi- 
togenic effect of IL l .  
The proliferative response of thymocytes was strictly 
dependent  on  the IL 1 concentration in the  cultures (Fig. 
1) and  was independent of the IL 2  source or  concentra- 
tlon.  The possible effect of contaminating mitogen was 
further ruled out by the dose-dependent  inhibition of the 
proliferative response by specific ant" 1 IgG (Table I). 
Induction of IL 2 responsiveness by IL 1 seems  to be 
mediated by a  concerted  action of IL 1 and IL 2  on the 
induction of IL 2  receptors. I t  is not  clear  whether this is 
a  direct  synergistic  effect of IL 1 and IL 2  or an  effect 
mediated by another factor. 
The PNA- medullary type of thymocytes appears to be 
the target population of IL 1-mediated IL 2 production 
(13).  The  same  thymic  subpopulation  was  found  to be 
responsive  to the IL 1/IL 2  synergism described in  this 
report (Table 111). The proliferative responses of  PNA- 
thymocytes  correlated  qualitatively  with  those of unsep- 
arated thymocytes but were significantly higher. Cul- 
tures  containing PNAf thymocytes were unable  to  use IL 
2  upon a mitogenic stimulus.  This is in  contrast o  earlier 
reports by Conlon et  al. (1 3) but  can be explained by the 
higher  purity of the PNA+ cells recovered from cell sorting 
as  opposed to precipitation of agglutinated cells (12). 
Thus,  the  data reported here clearly suggest that in  ad- 
dition to promoting IL 2 production by activated T cells, 
IL 1 may play an  additional augmenting role in T cell 
activation. Because IL 1 itself does  not  induce IL 2 recep- 
tor  expression  on the cell surface,  the mechanism of this 
IL 1 mitogenic effect seems  to be more complex. Under 
our experimental conditions, IL 2 could be required to 
expand the few PNA- thymocytes that  express IL 2 recep- 
tors  after induction by IL 1. However, pulse  kinetics  with 
PNA- thymocytes revealed that short  exposure to IL 1 (up 
to 16 hr) did not induce  measurable IL 2  receptors, and 
after longer exposure to IL 1 alone, cell viability was 
drastically  decreased. How exactly IL 1 cooperates with 
IL 2  to  induce IL 2 receptor expression  within a PNA- 
thymocyte population will be the subject of further  stud- 
ies. 
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